Linaclotide
Who holds supplier records for Linaclotide? 15 organisations hold a current record for Linaclotide: an active US FDA Type II Drug Master File. A further 1 organisation has only historical (inactive) DMF filings. Recorded organisation countries for current records: China (8), India (2), Sweden (1), United States (1) and 1 other country (1); not recorded for 2.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Linaclotide: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/linaclotide
Reading the evidence
- 15 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in China
8 of the 13 current records with a recorded country list China. Organisation country is not necessarily the manufacturing site.
- 5 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
- US product patents listed
The latest patent listed in the FDA Orange Book for an approved product containing Linaclotide expires 16 Feb 2034. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.
Current records (15)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Linaclotide. Country is the organisation's recorded country, not necessarily the manufacturing site.
- Hybio Pharmaceutical Co., Ltd.China Company GMP cert on recordActive DMF 37370, 32314 · latest filing Aug 2022
- AURO PEPTIDES LTDActive DMF 29708 · latest filing Sept 2015
- CHENGDU SHENGNUO BIOPHARM CO LTDChinaActive DMF 35812 · latest filing Apr 2021
- CORDEN PHARMA COLORADO INCActive DMF 24992 · latest filing May 2011
- HAINAN SHUANGCHENG PHARMACEUTICALS CO LTDChinaActive DMF 42040 · latest filing Jun 2025
- HANGZHOU THINHEAL PHARMA-TECH CO LTDChinaActive DMF 39901 · latest filing Jun 2024
- MSN LIFE SCIENCES PRIVATE LIMITEDIndia Company GMP cert on recordActive DMF 30421, 31351 · latest filing Feb 2017
- PolyPeptide Laboratories (Sweden) ABSweden Company GMP cert on recordActive DMF 25021 · latest filing Jun 2011
- POLYPEPTIDE LABORATORIES INCUnited StatesActive DMF 25025 · latest filing Jun 2011
- Sun Pharmaceutical Industries LimitedIndia Company GMP cert on recordActive DMF 30266 · latest filing Nov 2016
- SUZHOU TIANMA PHARMA GROUP TIANJI BIO-PHARMACEUTICAL CO LTDChinaActive DMF 42635 · latest filing Sept 2025
- TAPI NL BVNetherlandsActive DMF 30274 · latest filing Mar 2016
- Wisdom Pharmaceutical Co., LtdChinaActive DMF 44235 · latest filing May 2026
- ZHEJIANG PEPTITES BIOTECH CO LTDChinaActive DMF 42049 · latest filing Jun 2025
- Zhejiang Supor Pharmaceuticals Co., LtdChina Company GMP cert on recordActive DMF 43837 · latest filing Mar 2026
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Historical records (1)
Organisations whose Type II DMFs for Linaclotide are no longer active. These show a past filing, not current supply.
Show all 1 historical record
- BACHEM AMERICAS INCInactive DMF 28273 · filed May 2014
US product patents and exclusivity
The FDA Orange Book lists patents and exclusivities for specific approved products (4 listed products contain Linaclotide). The latest listed patent expires 16 Feb 2034. The latest listed exclusivity runs to 21 May 2029. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.
Overview
Linaclotide is a guanylate cyclase-C agonist used to treat irritable bowel syndrome with constipation and chronic idiopathic constipation. It works by increasing the secretion of chloride and bicarbonate into the intestinal lumen, resulting in increased intestinal fluid and accelerated transit.
Chemical identity
- IUPAC name
- (2S)-2-[[(1R,4S,7S,13S,16R,21R,24R,27S,30S,33R,38R,44S)-21-amino-13-(2-amino-2-oxoethyl)-27-(2-carboxyethyl)-44-[(1R)-1-hydroxyethyl]-30-[(4-hydroxyphenyl)methyl]-4-methyl-3,6,12,15,22,25,28,31,40,43,46,51-dodecaoxo-18,19,35,36,48,49-hexathia-2,5,11,14,23,26,29,32,39,42,45,52-dodecazatetracyclo[22.22.4.216,33.07,11]dopentacontane-38-carbonyl]amino]-3-(4-hydroxyphenyl)propanoic acid
- Canonical SMILES
- C[C@H]1C(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@H](NC(=O)CNC(=O)[C@@H](NC2=O)[C@@H](C)O)C(=O)N[C@@H](CC4=CC=C(C=C4)O)C(=O)O)C(=O)N[C@@H](CSSC[C@@H](C(=O)N3)N)C(=O)N[C@H](C(=O)N5CCC[C@H]5C(=O)N1)CC(=O)N)CC6=CC=C(C=C6)O)CCC(=O)O
- InChIKey
- KXGCNMMJRFDFNR-WDRJZQOASA-N
- Synonyms
- Linzess API, asp-0456, asp0456, linzess, md-1100, md-7246 (delayed release formulation)
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Guanylate Cyclase-C Agonist
- Mechanism of action
- Guanylate Cyclase Activators
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Linaclotide?
15 organisations hold an active US FDA Type II Drug Master File or a CEP for Linaclotide: Hybio Pharmaceutical Co., Ltd. (China), AURO PEPTIDES LTD, CHENGDU SHENGNUO BIOPHARM CO LTD (China), CORDEN PHARMA COLORADO INC, HAINAN SHUANGCHENG PHARMACEUTICALS CO LTD (China), HANGZHOU THINHEAL PHARMA-TECH CO LTD (China), MSN LIFE SCIENCES PRIVATE LIMITED (India) and PolyPeptide Laboratories (Sweden) AB (Sweden), and 7 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Linaclotide Drug Master Files are active?
Hybio Pharmaceutical Co., Ltd. (DMF 37370, 32314), AURO PEPTIDES LTD (DMF 29708), CHENGDU SHENGNUO BIOPHARM CO LTD (DMF 35812), CORDEN PHARMA COLORADO INC (DMF 24992), HAINAN SHUANGCHENG PHARMACEUTICALS CO LTD (DMF 42040), HANGZHOU THINHEAL PHARMA-TECH CO LTD (DMF 39901), MSN LIFE SCIENCES PRIVATE LIMITED (DMF 30421, 31351) and PolyPeptide Laboratories (Sweden) AB (DMF 25021) and 7 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Linaclotide records mean?
1 organisation has only inactive Type II DMFs for Linaclotide. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does the FDA Orange Book list patents for products containing Linaclotide?
Yes. The latest patent listed for an approved US product containing Linaclotide expires 16 Feb 2034, across 4 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.
How do I qualify a Linaclotide supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Linaclotide?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.